Dietary Factors and Biomarkers Involved in the Methylenetetrahydrofolate Reductase Genotype–Colorectal Adenoma Pathway
Authors:
- María Elena MartínezMaría Elena Martínez
- Patricia ThompsonPTPatricia Thompson
- Elizabeth T. JacobsEJElizabeth T. Jacobs
- Edward GiovannucciEGEdward Giovannucci
- Ruiyun JiangRJRuiyun Jiang
- Walt KlimeckiWKWalt Klimecki
- David S. AlbertsDADavid S. Alberts
- 1 December 2006
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 131 (6) , 1706-1716
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrenceInternational Journal of Cancer, 2006
- Methylenetetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in MexicoEuropean Journal of Cancer, 2006
- Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overviewJournal of Inherited Metabolic Disease, 2006
- Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk populationDiseases of the Esophagus, 2005
- Dose-Related Association of MTHFR 677T Allele With Risk of Ischemic StrokeStroke, 2005
- Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemiaThe Pharmacogenomics Journal, 2003
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991